Literature DB >> 26338038

Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.

Elena López-Isac1, Diana Campillo-Davo1, Lara Bossini-Castillo1, Sandra G Guerra2, Shervin Assassi3, Carmen Pilar Simeón4, Patricia Carreira5, Norberto Ortego-Centeno6, Paloma García de la Peña7, Lorenzo Beretta8, Alessandro Santaniello8, Chiara Bellocchi8, Claudio Lunardi9, Gianluca Moroncini10, Armando Gabrielli10, Gabriela Riemekasten11, Torsten Witte12, Nicolas Hunzelmann13, Alexander Kreuter14, Jörg Hw Distler15, Alexandre E Voskuyl16, Jeska de Vries-Bouwstra17, Ariane Herrick18, Jane Worthington18, Christopher P Denton2, Carmen Fonseca2, Timothy Rdj Radstake19, Maureen D Mayes3, Javier Martín1.   

Abstract

OBJECTIVES: TYK2 is a common genetic risk factor for several autoimmune diseases. This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc). Therefore, we aimed to assess the possible role of this locus in SSc.
METHODS: This study comprised a total of 7103 patients with SSc and 12 220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK. Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus. Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression. Meta-analyses were performed using the inverse variance method.
RESULTS: Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis (p=3.08×10(-13), OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals (p=2.28×10(-3), OR=0.80; p=1.27×10(-3), OR=0.59; p=2.63×10(-5), OR=0.83, respectively). Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants.
CONCLUSIONS: We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Cytokines; Gene Polymorphism; Systemic Sclerosis; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26338038      PMCID: PMC7228811          DOI: 10.1136/annrheumdis-2015-208154

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.

Authors:  Lara Bossini-Castillo; Jose-Ezequiel Martin; Jasper Broen; Olga Gorlova; Carmen P Simeón; Lorenzo Beretta; Madelon C Vonk; Jose Luis Callejas; Ivan Castellví; Patricia Carreira; Francisco José García-Hernández; Mónica Fernández Castro; Marieke J H Coenen; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Bobby P Koeleman; Alexandre E Voskuyl; Annemie J Schuerwegh; Øyvind Palm; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Raffaella Scorza; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Filemon K Tan; Frank C Arnett; Sandeep K Agarwal; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Hum Mol Genet       Date:  2011-11-10       Impact factor: 6.150

Review 2.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

3.  Identification of multiple genetic susceptibility loci in Takayasu arteritis.

Authors:  Güher Saruhan-Direskeneli; Travis Hughes; Kenan Aksu; Gokhan Keser; Patrick Coit; Sibel Z Aydin; Fatma Alibaz-Oner; Sevil Kamalı; Murat Inanc; Simon Carette; Gary S Hoffman; Servet Akar; Fatos Onen; Nurullah Akkoc; Nader A Khalidi; Curry Koening; Omer Karadag; Sedat Kiraz; Carol A Langford; Carol A McAlear; Zeynep Ozbalkan; Askin Ates; Yasar Karaaslan; Kathleen Maksimowicz-McKinnon; Paul A Monach; Hüseyin T Ozer; Emire Seyahi; Izzet Fresko; Ayse Cefle; Philip Seo; Kenneth J Warrington; Mehmet A Ozturk; Steven R Ytterberg; Veli Cobankara; A Mesut Onat; Joel M Guthridge; Judith A James; Ercan Tunc; Nurşen Duzgun; Muge Bıcakcıgil; Sibel P Yentür; Peter A Merkel; Haner Direskeneli; Amr H Sawalha
Journal:  Am J Hum Genet       Date:  2013-07-03       Impact factor: 11.025

Review 4.  Genetic insights into common pathways and complex relationships among immune-mediated diseases.

Authors:  Miles Parkes; Adrian Cortes; David A van Heel; Matthew A Brown
Journal:  Nat Rev Genet       Date:  2013-08-06       Impact factor: 53.242

5.  Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

Authors:  Christopher E M Griffiths; Bruce E Strober; Peter van de Kerkhof; Vincent Ho; Roseanne Fidelus-Gort; Newman Yeilding; Cynthia Guzzo; Yichuan Xia; Bei Zhou; Shu Li; Lisa T Dooley; Neil H Goldstein; Alan Menter
Journal:  N Engl J Med       Date:  2010-01-14       Impact factor: 91.245

6.  Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Authors:  Anna Hellquist; Tiina M Järvinen; Sari Koskenmies; Marco Zucchelli; Christina Orsmark-Pietras; Linda Berglind; Jaana Panelius; Taina Hasan; Heikki Julkunen; Mauro D'Amato; Ulpu Saarialho-Kere; Juha Kere
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.

Authors:  Maureen D Mayes; Lara Bossini-Castillo; Olga Gorlova; José Ezequiel Martin; Xiaodong Zhou; Wei V Chen; Shervin Assassi; Jun Ying; Filemon K Tan; Frank C Arnett; John D Reveille; Sandra Guerra; María Teruel; Francisco David Carmona; Peter K Gregersen; Annette T Lee; Elena López-Isac; Eguzkine Ochoa; Patricia Carreira; Carmen Pilar Simeón; Iván Castellví; Miguel Ángel González-Gay; Alexandra Zhernakova; Leonid Padyukov; Marta Alarcón-Riquelme; Cisca Wijmenga; Matthew Brown; Lorenzo Beretta; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Alexandre E Voskuyl; Annemie J Schuerwegh; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Fredrick M Wigley; Laura K Hummers; John Varga; Monique E Hinchcliff; Murray Baron; Marie Hudson; Janet E Pope; Daniel E Furst; Dinesh Khanna; Kristin Phillips; Elena Schiopu; Barbara M Segal; Jerry A Molitor; Richard M Silver; Virginia D Steen; Robert W Simms; Robert A Lafyatis; Barri J Fessler; Tracy M Frech; Firas Alkassab; Peter Docherty; Elzbieta Kaminska; Nader Khalidi; Henry Niall Jones; Janet Markland; David Robinson; Jasper Broen; Timothy R D J Radstake; Carmen Fonseca; Bobby P Koeleman; Javier Martin
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

9.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Authors:  Lam C Tsoi; Sarah L Spain; Jo Knight; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jun Ding; Yanming Li; Trilokraj Tejasvi; Johann E Gudjonsson; Hyun M Kang; Michael H Allen; Ross McManus; Giuseppe Novelli; Lena Samuelsson; Joost Schalkwijk; Mona Ståhle; A David Burden; Catherine H Smith; Michael J Cork; Xavier Estivill; Anne M Bowcock; Gerald G Krueger; Wolfgang Weger; Jane Worthington; Rachid Tazi-Ahnini; Frank O Nestle; Adrian Hayday; Per Hoffmann; Juliane Winkelmann; Cisca Wijmenga; Cordelia Langford; Sarah Edkins; Robert Andrews; Hannah Blackburn; Amy Strange; Gavin Band; Richard D Pearson; Damjan Vukcevic; Chris C A Spencer; Panos Deloukas; Ulrich Mrowietz; Stefan Schreiber; Stephan Weidinger; Sulev Koks; Külli Kingo; Tonu Esko; Andres Metspalu; Henry W Lim; John J Voorhees; Michael Weichenthal; H Erich Wichmann; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Christopher E M Griffiths; Andre Reis; Juha Kere; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; James T Elder; Richard C Trembath
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus.

Authors:  Deborah S Cunninghame Graham; David L Morris; Tushar R Bhangale; Lindsey A Criswell; Ann-Christine Syvänen; Lars Rönnblom; Timothy W Behrens; Robert R Graham; Timothy J Vyse
Journal:  PLoS Genet       Date:  2011-10-27       Impact factor: 5.917

View more
  16 in total

Review 1.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

2.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Genetics of systemic sclerosis.

Authors:  Yuki Ishikawa; Chikashi Terao
Journal:  J Scleroderma Relat Disord       Date:  2020-04-19

4.  Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?

Authors:  Minghua Wu; Shervin Assassi
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-10-19

5.  Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation.

Authors:  Blagoje Soskic; Eddie Cano-Gamez; Deborah J Smyth; Kirsty Ambridge; Ziying Ke; Julie C Matte; Lara Bossini-Castillo; Joanna Kaplanis; Lucia Ramirez-Navarro; Anna Lorenc; Nikolina Nakic; Jorge Esparza-Gordillo; Wendy Rowan; David Wille; David F Tough; Paola G Bronson; Gosia Trynka
Journal:  Nat Genet       Date:  2022-05-26       Impact factor: 41.307

6.  Therapeutic molecular targets of SSc-ILD.

Authors:  Yun Zhang; Jörg Hw Distler
Journal:  J Scleroderma Relat Disord       Date:  2020-01-22

7.  Comprehensive analysis of three TYK2 gene variants in the susceptibility to Chagas disease infection and cardiomyopathy.

Authors:  Daniel A Leon Rodriguez; Marialbert Acosta-Herrera; F David Carmona; Nuria Dolade; Sofia Vargas; Luis Eduardo Echeverría; Clara Isabel González; Javier Martin
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 8.  Updates on genetics in systemic sclerosis.

Authors:  Yuko Ota; Masataka Kuwana
Journal:  Inflamm Regen       Date:  2021-06-15

9.  Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.

Authors:  Chenxi Liu; Songxin Yan; Haizhen Chen; Ziyan Wu; Liubing Li; Linlin Cheng; Haolong Li; Yongzhe Li
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.

Authors:  Nadia D Morgan; Ami A Shah; Maureen D Mayes; Robyn T Domsic; Thomas A Medsger; Virginia D Steen; John Varga; Mary Carns; Paula S Ramos; Richard M Silver; Elena Schiopu; Dinesh Khanna; Vivien Hsu; Jessica K Gordon; Heather Gladue; Lesley A Saketkoo; Lindsey A Criswell; Chris T Derk; Marcin A Trojanowski; Victoria K Shanmugam; Lorinda Chung; Antonia Valenzuela; Reem Jan; Avram Goldberg; Elaine F Remmers; Daniel L Kastner; Fredrick M Wigley; Pravitt Gourh; Francesco Boin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.